Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLε)-mutated solid tumours in the GARNET study

被引：0

作者：

Samuel, L.

Miller, R.

Ross, P.

Arkenau, T. ^{[1
]}

Antony, G. ^{[2
]}

Veneris, J.

Rule, J. ^{[2
]}

Starling, N. ^{[3
]}

机构：

[1] Sarah Cannon Res Inst, London, England

[2] GlaxoSmithKline, London, England

[3] Royal Marsden, London, England

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

基金：

芬兰科学院;

关键词：

D O I：

10.1016/j.annonc.2023.04.220

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-164

引用

页码：S73 / S74

页数：2

共 50 条

[1] Dostarlimab in advanced/recurrent (A/R) mismatch repair deficient/microsatellite instability-high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): the GARNET study
Oaknin, Ana
Pothuri, Bhavana
Gilbert, Lucy
Sabatier, Renaud
Ghamande, Sharad
Gravina, Adriano
Calvo, Emiliano
Banerjee, Susana
Mangan, Niamh
Miller, Rowan E.
Pikiel, Joanna
Mirza, Mansoor R.
Duan, Tao
Zildjian, Sybil
Zografos, Eleftherios
Veneris, Jennifer
Tinker, Anna V.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 133 - 134
[2] Dostarlimab in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability-high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): The GARNET study.
Oaknin, Ana
Pothuri, Bhavana
Gilbert, Lucy
Sabatier, Renaud
Ghamande, Sharad A.
Gravina, Adriano
Calvo, Emiliano
Banerjee, Susana N.
Miller, Rowan
Pikiel, Joanna
Mirza, Mansoor Raza
Duan, Tao
Zildjian, Sybil
Zografos, Eleftherios
Veneris, Jennifer Taylor
Tinker, Anna
Powell, Matthew A.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[3] Clinicopathological and genomic characteristics of DNA Mismatch Repair-Deficient (dMMR) and microsatellite instability-high (MSI-H) resected gastric adenocarcinoma
Zhou, J.
Liang, B.
Yin, M.
Zhang, H.
Liu, F.
Dong, L.
Zhang, B.
Xu, Y.
ANNALS OF ONCOLOGY, 2020, 31 : S921 - S922
[4] Epidemiology of Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (dMMR) in Solid Tumors: A Structured Literature Review
Lorenzi, Maria
Amonkar, Mayur
Zhang, Jacky
Mehta, Shivani
Liaw, Kai-Li
JOURNAL OF ONCOLOGY, 2020, 2020
[5] Primary analysis of GEICO 120/DORA, a real-world multicentre study of dostarlimab in patients with recurrent or advanced DNA mismatch repair deficient/microsatellite instability-high (DMMR/MSI-H) endometrial cancer
Gallego, Alejandro
Madariaga, Ainhoa
Estevez-Garcia, Purificacion
Alberti, Facundo
Carbo, Anna
Palacio, Isabel
Churruca, Cristina
Galvez, Fernando
Ortega, M. Eugenia
Murata, Paola
Manzano, Aranzazu
Masvidal, Maria
Martin-Lorente, Cristina
Hernando, Blanca
Lozano, Inmaculada
Cueva, Juan F.
Garcia-Illescas, David
Falco, Esther
Mendiola, Marta
Redondo, Andres
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A182 - A182
[6] The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world.
Chakrabarti, Sakti
Parish, Marie
Peterson, Carrie
Ludwig, Kirk A.
Sriram, Deepika
Ruggeri, Antony
Tolay, Sameer
Selfridge, Jennifer Eva
Bajor, David L.
Mohamed, Amr
Mahipal, Amit
Shreenivas, Aditya V.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 105 - 105
[7] STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS
Lorenzi, M.
Amonkar, M.
Zhang, J.
Mehta, S.
Liaw, K.
VALUE IN HEALTH, 2018, 21 : S22 - S23
[8] Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET - a phase I, single-arm study
Oaknin, Ana
Gilbert, Lucy
Tinker, Anna, V
Brown, Jubilee
Mathews, Cara
Press, Joshua
Sabatier, Renaud
O'Malley, David M.
Samouelian, Vanessa
Boni, Valentina
Duska, Linda
Ghamande, Sharad
Ghatage, Prafull
Kristeleit, Rebecca
Leath, Charles, III
Guo, Wei
Im, Ellie
Zildjian, Sybil
Han, Xinwei
Duan, Tao
Veneris, Jennifer
Pothuri, Bhavana
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
[9] Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Geurts, Birgit S.
Battaglia, Thomas W.
Henegouwen, J. Maxime van Berge
Zeverijn, Laurien J.
de Wit, Gijs F.
Hoes, Louisa R.
van der Wijngaart, Hanneke
van der Noort, Vincent
Roepman, Paul
de Leng, Wendy W. J.
Jansen, Anne M. L.
Opdam, Frans L.
de Jonge, Maja J. A.
Cirkel, Geert A.
Labots, Mariette
Hoeben, Ann
Kerver, Emile D.
Bins, Adriaan D.
Erdkamp, Frans G. L.
van Rooijen, Johan M.
Houtsma, Danny
Hendriks, Mathijs P.
de Groot, Jan-Willem B.
Verheul, Henk M. W.
Gelderblom, Hans
Voest, Emile E.
BMC CANCER, 2023, 23 (01)
[10] Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Birgit S. Geurts
Thomas W. Battaglia
J. Maxime van Berge Henegouwen
Laurien J. Zeverijn
Gijs F. de Wit
Louisa R. Hoes
Hanneke van der Wijngaart
Vincent van der Noort
Paul Roepman
Wendy W. J. de Leng
Anne M. L. Jansen
Frans L. Opdam
Maja J. A. de Jonge
Geert A. Cirkel
Mariette Labots
Ann Hoeben
Emile D. Kerver
Adriaan D. Bins
Frans G.L. Erdkamp
Johan M. van Rooijen
Danny Houtsma
Mathijs P. Hendriks
Jan-Willem B. de Groot
Henk M. W. Verheul
Hans Gelderblom
Emile E. Voest
BMC Cancer, 23

← 1 2 3 4 5 →